AVEO Pharmaceuticals, Inc

(NASDAQ:AVEO)

Latest On AVEO Pharmaceuticals, Inc (AVEO):

Date/Time Type Description Signal Details
2023-01-06 09:29 ESTNewsAveo Oncology shareholders approve acquisition by LG ChemN/A
2022-11-08 08:38 ESTNewsAVEO Pharmaceuticals GAAP EPS of -$0.09 beats by $0.08, revenue of $30.4M beats by $0.54MN/A
2022-10-24 19:07 ESTNewsAVEO Oncology: The Latest Acquisition Signals More DealsN/A
2022-10-18 16:06 ESTNewsAVEO Oncology shares jumped on acquisition by LG Chem for $15.00 per share in cashN/A
2022-08-16 04:47 ESTNewsA Current Assessment On AVEO PharmaceuticalsN/A
2022-08-04 23:48 ESTNewsAVEO Pharmaceuticals GAAP EPS of -$0.24 beats by $0.04, revenue of $25.3M misses by $0.17MN/A
2022-08-04 23:48 ESTNewsAVEO Pharmaceuticals, Inc. (AVEO) CEO Michael Bailey on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-03 17:46 ESTNewsAVEO Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-22 16:02 ESTNewsAVEO Oncology partners with Eli Lilly to develop and supply head and neck cancer combo therapyN/A
2022-05-24 14:40 ESTNewsAVEO Pharmaceuticals Is Primed For A BreakoutN/A
2022-05-05 22:42 ESTNewsAVEO Pharmaceuticals GAAP EPS of -$0.30, revenue of $20.9MN/A
2022-05-05 22:39 ESTNewsAVEO Pharmaceuticals' (AVEO) CEO Michael Bailey on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 23:52 ESTNewsAVEO Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-03-15 00:14 ESTNewsAVEO Pharmaceuticals Inc's (AVEO) CEO Michael Bailey on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-14 07:27 ESTNewsAVEO Pharmaceuticals GAAP EPS of -$0.21 beats by $0.07, revenue of $17.65M misses by $0.7MN/A
2022-03-09 03:40 ESTNewsAVEO Pharmaceuticals: Finally Ready To RebootN/A
2022-01-05 17:47 ESTNewsAVEO Oncology slips 10% despite deal to evaluate Fotivda in combination for kidney cancerN/A
2021-12-01 18:08 ESTNewsAVEO Oncology names Jeb Ledell as COON/A
2021-11-09 04:21 ESTNewsAVEO Pharmaceuticals EPS beats by $0.06, beats on revenueN/A
2021-11-09 04:20 ESTNewsAveo plans to begin manufacturing clinical supply of biologic for head and neck cancerN/A
2021-11-09 04:20 ESTNewsAVEO Pharmaceuticals, Inc. (AVEO) CEO Michael Bailey on Q3 2021 Results - Earning Call TranscriptN/A
2021-11-08 08:02 ESTNewsAVEO Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-29 14:32 ESTNewsAVEO Pharmaceuticals: Sticking To The PlanN/A
2021-09-21 12:44 ESTNewsAVEO Oncology granted FDA’s Fast Track Designation for cancer therapyN/A
2021-08-05 22:40 ESTNewsAVEO Pharmaceuticals EPS beats by $0.10, beats on revenueN/A
2021-08-05 22:40 ESTNewsAVEO Pharmaceuticals, Inc. (AVEO) CEO Michael Bailey on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-24 08:24 ESTNewsAVEO Pharmaceuticals: Making Its Mark In Cancer TreatmentN/A
2021-07-20 20:54 ESTNewsAVEO Oncology: Time To Be PatientN/A
2021-03-30 02:30 ESTNewsAVEO's FOTIVDA added to NCNN clinical practice guidelinesN/A
2021-03-27 00:07 ESTNewsAVEO Oncology ends stock offering, grosses $55MN/A
2021-03-24 14:45 ESTNewsAVEO raises $48M capital via equity offeringN/A
2021-03-22 23:11 ESTNewsAVEO says FOTIVDA now commercially available in U.S.N/A
2021-03-22 23:10 ESTNewsAVEO under pressure on launching 5M stock offeringN/A
2021-03-18 08:12 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 19:10 ESTNewsAVEO: Drug Approved, But Still A Long Way To Go Before Self SufficiencyN/A
2021-03-17 12:08 ESTEarnings EstimateAn EPS average of -$0.50 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-17 12:08 ESTEarnings EstimateAn EPS average of $0.03 is estimated for the 2022 year.Buy
2021-03-16 20:07 ESTNewsAVEO Oncology to regain ex-North American rights to oncology drug, AV-203N/A
2021-03-16 20:03 ESTNewsAVEO Pharmaceuticals EPS misses by $0.06, misses on revenueN/A
2021-03-12 20:58 ESTNewsAVEO Oncology shares surge on Fotvida deal with BMY in kidney cancerN/A
2021-03-12 11:09 ESTAnalyst RatingThe Analyst Target Price has increased from $12 to $22.75.Buy
2021-03-11 23:59 ESTNewsAVEO Oncology announces $20M tranche under Hercules debt facilityN/A
2021-03-11 03:24 ESTNewsAVEO surges on reports of FDA approval for Fotivda (update)N/A
2021-01-20 14:42 ESTNewsAVEO Oncology announces commitment for $10M loan from HerculesN/A
2021-01-20 07:10 ESTAnalyst RatingThe Analyst Target Price has increased from $11.25 to $12.Buy
2021-01-15 22:19 ESTNewsAveo's tivozanib combo demonstrates 29% partial response in liver cancer studyN/A
2021-01-07 23:22 ESTNewsAVEO outlines 2021 outlook; initiates Phase 1 trial for cancer complicationN/A
2021-01-02 15:10 ESTFinancialsCompany financials have been released.Neutral
2020-12-27 12:13 ESTNewsAVEO Oncology: Managing A Position Ahead Of Tivozanib's PDUFAN/A
2020-12-13 03:16 ESTFinancialsCompany financials have been released.Neutral

About AVEO Pharmaceuticals, Inc (AVEO):

AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes a portfolio of targeted medicines for oncology and other areas of unmet medical needs. It markets its lead candidate, tivozanib, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC). The company has also completed a Phase III TIVO-3 trial of tivozanib for the treatment of RCC; and initiated enrollment in a phase Ib/II clinical trial of tivozanib in combination with Opdivo (nivolumab), an immune checkpoint (PD-1) inhibitor for the treatment of RCC. In addition, it is developing Ficlatuzumab, a potent hepatocyte growth factor inhibitory antibody that is in a Phase II clinical trial for the treatment of squamous cell carcinoma of the head and neck, acute myeloid leukemia, and pancreatic cancer; and AV-203, a potent anti-ErbB3 specific monoclonal antibody, which has completed Phase I clinical trial for treating esophageal cancer. The company's preclinical stage products include AV-380, a potent humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; and AV-353 for the treatment of pulmonary arterial hypertension. AVEO Pharmaceuticals, Inc. has collaboration agreements with CANbridge Life Sciences Ltd.; EUSA Pharma (UK) Limited; Novartis International Pharmaceutical Ltd.; Biodesix, Inc.; St. Vincent's Hospital Sydney Limited; Biogen Idec International GmbH; and Kyowa Kirin Co., Ltd.; AstraZeneca PLC; and Bristol Myers Squibb. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Boston, Massachusetts.

See Advanced Chart

General

  • Name AVEO Pharmaceuticals, Inc
  • Symbol AVEO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1:10
  • Last Split Date2020-02-20
  • Fiscal Year EndDecember
  • IPO Date2010-03-12
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.aveooncology.com
View More

Valuation

  • Trailing PE 84.8
  • Price/Sales (Trailing 12 Mt.) 39.54
  • Price/Book (Most Recent Quarter) 8.55
  • Enterprise Value Revenue 42.27
  • Enterprise Value EBITDA 48.85
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.04
  • Next Year EPS Estimate -$0.17
  • Next Quarter EPS Estimate -$0.54
  • Operating Margin -646%
  • Return on Assets -41%
  • Return on Equity -142%
  • Revenue 6.02 million
  • Earnings Per Share $0.03
  • Revenue Per Share $0.28
  • Gross Profit -16660000
  • Quarterly Earnings Growth 16%
View More

Highlights

  • Market Capitalization 276.18 million
  • Analyst Target Price $22.75
  • Book Value Per Share $1.31
View More

Share Statistics

  • Shares Outstanding 27.13 million
  • Shares Float 23.33 million
  • % Held by Insiders 14%
  • % Held by Institutions 34.07%
  • Shares Short 1.16 million
  • Shares Short Prior Month 911893
  • Short Ratio 2.74
  • Short % of Float 4%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.24
  • 52 Week High $13.21
  • 52 Week Low $2.4
  • 50 Day Moving Average 9.11
  • 200 Day Moving Average 6.8
View More

Dividends

  • Dividend Date 2020-02-20
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

AVEO Pharmaceuticals, Inc (AVEO) Dividend Calendar:

AVEO's last dividend payment was made to shareholders on February 20, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

AVEO Pharmaceuticals, Inc (AVEO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$886000-$0.44-$0.38-15.79%
2020-09-302020-11-09$N/A-$0.33-$0.23-45.05%
2020-06-302020-08-10$N/A-$0.42-$0.6130.58%
2020-03-312020-04-30$N/A-$0.52-$0.50-4.69%
2019-12-312020-03-16$764000-$0.28-$0.5851.45%
2019-09-302019-11-12$25.72 million$1.00$0.30233.33%
2019-06-302019-08-08$703000-$0.20-$0.6569.23%
2019-03-312019-05-09$1.61 million$0.04-$0.55107.64%
2018-12-312019-03-14$1.48 million$1.80-$0.55427.27%
2018-09-302018-11-09$2.47 million-$1.80-$0.63-184.23%
2018-06-302018-08-07$433000$0.30-$0.63147.37%
2018-03-312018-05-08$1.03 million-$0.80-$0.70-14.29%
2017-12-312018-03-13$82000$0.27-$0.30189.67%
2017-09-302017-11-07$4.61 million-$2.20-$0.50-340%
2017-06-302017-08-09$351000-$3.00-$0.90-233.33%
2017-03-312017-05-04$2.53 million-$1.20-$1.200%
2016-12-312017-03-22$127000-$0.70-$1.2041.67%
2016-09-302016-11-04$992000-$0.70-$1.1539.13%
2016-06-302016-08-04$193000-$1.14-$1.4018.79%
2016-03-312016-05-10$1.2 million-$1.30-$1.300%
2015-12-312016-03-15$3.6 million-$0.11-$0.04-175%
2015-09-302015-11-09$15.16 million$0.14-$0.09255.56%
2015-06-302015-08-10$134000-$0.10-$0.2050%
2015-03-312015-05-07$134000-$0.21-$0.2412.5%
2014-12-312015-03-06$116000-$0.27-$0.21-28.57%
2014-09-302014-11-05$872000-$0.28-$0.23-21.74%
2014-06-302014-08-11$1.85 million-$0.35-$0.4420.45%
2014-03-312014-05-07$15.29 million-$1.20-$4.0270.15%
2013-12-312014-03-13$323000-$3.20-$3.251.54%
2013-09-302013-11-07$323000-$4.70-$4.710.21%
2013-06-302013-08-08$324000-$4.70-$5.6116.22%
2013-03-312013-04-29$323000-$6.90-$7.194.03%
2012-12-312013-02-13$15.53 million-$4.30-$7.6944.08%
2012-09-302012-10-30$1.02 million-$6.90-$8.6620.32%
2012-06-302012-08-02$1.88 million-$6.80-$8.9123.68%
2012-03-312012-05-03$860000-$7.70-$7.61-1.18%
2011-12-312012-02-14$1.1 million-$5.80-$6.125.23%
2011-09-302011-11-02$3.59 million-$5.50-$5.500%
2011-06-302011-07-28$26.55 million-$1.60-$7.5278.72%
2011-03-312011-04-28$133.61 million$22.80-$5.67502.12%
2010-12-312011-02-16$11.96 million-$3.00-$6.4253.27%
2010-09-302010-11-04$6.22 million-$6.00-$6.172.76%
2010-06-302010-07-29$15.62 million-$5.00-$3.50-42.86%
2010-03-312010-04-29$10.88 million-$6.90-$7.001.43%

AVEO Pharmaceuticals, Inc (AVEO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

AVEO Pharmaceuticals, Inc (AVEO) Chart:

AVEO Pharmaceuticals, Inc (AVEO) News:

Below you will find a list of latest news for AVEO Pharmaceuticals, Inc (AVEO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

AVEO Pharmaceuticals, Inc (AVEO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest AVEO Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST162$3.99
Jun 13, 2022 7:58 PM EST238$3.99
Jun 13, 2022 7:58 PM EST262$3.99
Jun 13, 2022 7:58 PM EST200$4.005
Jun 13, 2022 7:59 PM EST11$4.015

AVEO Pharmaceuticals, Inc (AVEO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320017979/0000899243-20-017979-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1325879/000021545719006669/0000215457-19-006669-index.htm
2019-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1325879/000021545719007856/0000215457-19-007856-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319003033/0000899243-19-003033-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319003035/0000899243-19-003035-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319003036/0000899243-19-003036-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319003037/0000899243-19-003037-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319003040/0000899243-19-003040-index.htm
2019-03-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319005474/0000899243-19-005474-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319005477/0000899243-19-005477-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319016834/0000899243-19-016834-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319016835/0000899243-19-016835-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319016837/0000899243-19-016837-index.htm
2019-06-144/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319016960/0000899243-19-016960-index.htm
2019-11-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319027690/0000899243-19-027690-index.htm
2019-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319027691/0000899243-19-027691-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924319028068/0000899243-19-028068-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320000826/0000899243-20-000826-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320000827/0000899243-20-000827-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320003699/0000899243-20-003699-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320003700/0000899243-20-003700-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320003702/0000899243-20-003702-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320017965/0000899243-20-017965-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320017969/0000899243-20-017969-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320017970/0000899243-20-017970-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320017971/0000899243-20-017971-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000089924320017979/0000899243-20-017979-index.htm
2020-06-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1325879/000092963820000691/0000929638-20-000691-index.htm
2020-06-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1325879/000092963820000692/0000929638-20-000692-index.htm
2019-04-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1325879/000107261319000186/0001072613-19-000186-index.htm
2020-06-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1325879/000107261320000211/0001072613-20-000211-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1325879/000117266119000626/0001172661-19-000626-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312518352566/0001193125-18-352566-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519029719/0001193125-19-029719-index.htm
2019-02-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519042489/0001193125-19-042489-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519061139/0001193125-19-061139-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519082222/0001193125-19-082222-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519096024/0001193125-19-096024-index.htm
2019-04-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1325879/000119312519096640/0001193125-19-096640-index.htm
2019-04-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1325879/000119312519097940/0001193125-19-097940-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519097946/0001193125-19-097946-index.htm
2019-05-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1325879/000119312519162987/0001193125-19-162987-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519172470/0001193125-19-172470-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519209603/0001193125-19-209603-index.htm
2019-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519230981/0001193125-19-230981-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519241618/0001193125-19-241618-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519243888/0001193125-19-243888-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519247006/0001193125-19-247006-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519256524/0001193125-19-256524-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519261229/0001193125-19-261229-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519284004/0001193125-19-284004-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312519295580/0001193125-19-295580-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520002244/0001193125-20-002244-index.htm
2020-01-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1325879/000119312520013554/0001193125-20-013554-index.htm
2020-02-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1325879/000119312520023464/0001193125-20-023464-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520035652/0001193125-20-035652-index.htm
2020-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520042086/0001193125-20-042086-index.htm
2020-05-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1325879/000119312520153084/0001193125-20-153084-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520153095/0001193125-20-153095-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520155052/0001193125-20-155052-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520157210/0001193125-20-157210-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520165801/0001193125-20-165801-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1325879/000119312520169509/0001193125-20-169509-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520169515/0001193125-20-169515-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1325879/000119312520171444/0001193125-20-171444-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520171457/0001193125-20-171457-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520187888/0001193125-20-187888-index.htm
2020-09-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000119312520240516/0001193125-20-240516-index.htm
2020-06-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1325879/000119380520000719/0001193805-20-000719-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118061835/0001209191-18-061835-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118061837/0001209191-18-061837-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118061838/0001209191-18-061838-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118061839/0001209191-18-061839-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118061840/0001209191-18-061840-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118061841/0001209191-18-061841-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118061842/0001209191-18-061842-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118062247/0001209191-18-062247-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118062248/0001209191-18-062248-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118062249/0001209191-18-062249-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118062251/0001209191-18-062251-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118062252/0001209191-18-062252-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118062255/0001209191-18-062255-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118062256/0001209191-18-062256-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118062257/0001209191-18-062257-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118062258/0001209191-18-062258-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118064024/0001209191-18-064024-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118064025/0001209191-18-064025-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118064026/0001209191-18-064026-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118064027/0001209191-18-064027-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118064028/0001209191-18-064028-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118064029/0001209191-18-064029-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118064030/0001209191-18-064030-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118064031/0001209191-18-064031-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919118064032/0001209191-18-064032-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919119023995/0001209191-19-023995-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919119023996/0001209191-19-023996-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919119023997/0001209191-19-023997-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919119023998/0001209191-19-023998-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919119023999/0001209191-19-023999-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919119024000/0001209191-19-024000-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919119024002/0001209191-19-024002-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919119024004/0001209191-19-024004-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919119024005/0001209191-19-024005-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919120038234/0001209191-20-038234-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919120038235/0001209191-20-038235-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919120038238/0001209191-20-038238-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919120038240/0001209191-20-038240-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919120038243/0001209191-20-038243-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919120038244/0001209191-20-038244-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1325879/000120919120038246/0001209191-20-038246-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1325879/000156459019007804/0001564590-19-007804-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000156459019007810/0001564590-19-007810-index.htm
2019-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1325879/000156459019012116/0001564590-19-012116-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1325879/000156459019013948/0001564590-19-013948-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1325879/000156459019013954/0001564590-19-013954-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1325879/000156459019014349/0001564590-19-014349-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000156459019017563/0001564590-19-017563-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1325879/000156459019017952/0001564590-19-017952-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000156459019030409/0001564590-19-030409-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1325879/000156459019030755/0001564590-19-030755-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1325879/000156459019042532/0001564590-19-042532-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000156459019042534/0001564590-19-042534-index.htm
2019-12-16PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1325879/000156459019046077/0001564590-19-046077-index.htm
2020-01-08DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1325879/000156459020000448/0001564590-20-000448-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1325879/000156459020011145/0001564590-20-011145-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000156459020011147/0001564590-20-011147-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1325879/000156459020019292/0001564590-20-019292-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1325879/000156459020019299/0001564590-20-019299-index.htm
2020-04-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1325879/000156459020019921/0001564590-20-019921-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000156459020019949/0001564590-20-019949-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1325879/000156459020038899/0001564590-20-038899-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1325879/000156459020038919/0001564590-20-038919-index.htm
2019-03-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1325879/999999999719001377/9999999997-19-001377-index.htm
2019-05-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1325879/999999999719003671/9999999997-19-003671-index.htm
2019-11-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1325879/999999999719007724/9999999997-19-007724-index.htm
2020-04-23CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1325879/999999999720002042/9999999997-20-002042-index.htm
2020-04-23CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1325879/999999999720002043/9999999997-20-002043-index.htm

AVEO Pharmaceuticals, Inc (AVEO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AVEO Pharmaceuticals, Inc (AVEO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 14%
Institutional Ownership: 3407%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-06Anthony A. Jr. Florence10% Share HolderBuy27,300.001.9954,414.3620,191,738.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061837/0001209191-18-061837-index.htm
2018-12-06DAVID M MOTT10% Share HolderBuy27,300.001.9954,414.3620,191,738.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061840/0001209191-18-061840-index.htm
2018-12-06FOREST BASKETT10% Share HolderBuy27,300.001.9954,414.3620,191,738.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061835/0001209191-18-061835-index.htm
2018-12-06JOSHUA MAKOWER10% Share HolderBuy27,300.001.9954,414.3620,191,738.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061839/0001209191-18-061839-index.htm
2018-12-06Mohamad Makhzoumi10% Share HolderBuy27,300.001.9954,414.3620,191,738.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061838/0001209191-18-061838-index.htm
2018-12-06Peter W. Sonsini10% Share HolderBuy27,300.001.9954,414.3620,191,738.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061842/0001209191-18-061842-index.htm
2018-12-06SCOTT D SANDELL10% Share HolderBuy27,300.001.9954,414.3620,191,738.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061841/0001209191-18-061841-index.htm
2018-12-07Anthony A. Jr. Florence10% Share HolderBuy117,100.001.98232,361.5320,308,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061837/0001209191-18-061837-index.htm
2018-12-07DAVID M MOTT10% Share HolderBuy117,100.001.98232,361.5320,308,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061840/0001209191-18-061840-index.htm
2018-12-07FOREST BASKETT10% Share HolderBuy117,100.001.98232,361.5320,308,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061835/0001209191-18-061835-index.htm
2018-12-07JOSHUA MAKOWER10% Share HolderBuy117,100.001.98232,361.5320,308,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061839/0001209191-18-061839-index.htm
2018-12-07Mohamad Makhzoumi10% Share HolderBuy117,100.001.98232,361.5320,308,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061838/0001209191-18-061838-index.htm
2018-12-07Peter W. Sonsini10% Share HolderBuy117,100.001.98232,361.5320,308,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061842/0001209191-18-061842-index.htm
2018-12-07SCOTT D SANDELL10% Share HolderBuy117,100.001.98232,361.5320,308,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061841/0001209191-18-061841-index.htm
2018-12-10Anthony A. Jr. Florence10% Share HolderBuy26,000.001.9851,576.2020,334,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061837/0001209191-18-061837-index.htm
2018-12-10DAVID M MOTT10% Share HolderBuy26,000.001.9851,576.2020,334,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061840/0001209191-18-061840-index.htm
2018-12-10FOREST BASKETT10% Share HolderBuy26,000.001.9851,576.2020,334,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061835/0001209191-18-061835-index.htm
2018-12-10JOSHUA MAKOWER10% Share HolderBuy26,000.001.9851,576.2020,334,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061839/0001209191-18-061839-index.htm
2018-12-10Mohamad Makhzoumi10% Share HolderBuy26,000.001.9851,576.2020,334,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061838/0001209191-18-061838-index.htm
2018-12-10Peter W. Sonsini10% Share HolderBuy26,000.001.9851,576.2020,334,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061842/0001209191-18-061842-index.htm
2018-12-10SCOTT D SANDELL10% Share HolderBuy26,000.001.9851,576.2020,334,838.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118061841/0001209191-18-061841-index.htm
2018-12-11Anthony A. Jr. Florence10% Share HolderBuy61,200.001.98121,084.2020,396,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118062251/0001209191-18-062251-index.htm
2018-12-11DAVID M MOTT10% Share HolderBuy61,200.001.98121,084.2020,396,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118062256/0001209191-18-062256-index.htm
2018-12-11FOREST BASKETT10% Share HolderBuy61,200.001.98121,084.2020,396,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118062249/0001209191-18-062249-index.htm
2018-12-11Growth Equity Opportunities IV, LLC10% Share HolderBuy61,200.001.98121,084.2020,396,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118062247/0001209191-18-062247-index.htm
2018-12-11JOSHUA MAKOWER10% Share HolderBuy61,200.001.98121,084.2020,396,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118062255/0001209191-18-062255-index.htm
2018-12-11Mohamad Makhzoumi10% Share HolderBuy61,200.001.98121,084.2020,396,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118062252/0001209191-18-062252-index.htm
2018-12-11PETER J BARRIS10% Share HolderBuy61,200.001.98121,084.2020,396,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118062248/0001209191-18-062248-index.htm
2018-12-11Peter W. Sonsini10% Share HolderBuy61,200.001.98121,084.2020,396,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118062258/0001209191-18-062258-index.htm
2018-12-11SCOTT D SANDELL10% Share HolderBuy61,200.001.98121,084.2020,396,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118062257/0001209191-18-062257-index.htm
2018-12-20Anthony A. Jr. Florence10% Share HolderBuy200,000.001.63326,060.0020,596,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064027/0001209191-18-064027-index.htm
2018-12-20DAVID M MOTT10% Share HolderBuy200,000.001.63326,060.0020,596,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064030/0001209191-18-064030-index.htm
2018-12-20FOREST BASKETT10% Share HolderBuy200,000.001.63326,060.0020,596,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064026/0001209191-18-064026-index.htm
2018-12-20Growth Equity Opportunities IV, LLC10% Share HolderBuy200,000.001.63326,060.0020,596,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064024/0001209191-18-064024-index.htm
2018-12-20JOSHUA MAKOWER10% Share HolderBuy200,000.001.63326,060.0020,596,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064029/0001209191-18-064029-index.htm
2018-12-20Mohamad Makhzoumi10% Share HolderBuy200,000.001.63326,060.0020,596,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064028/0001209191-18-064028-index.htm
2018-12-20PETER J BARRIS10% Share HolderBuy200,000.001.63326,060.0020,596,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064025/0001209191-18-064025-index.htm
2018-12-20Peter W. Sonsini10% Share HolderBuy200,000.001.63326,060.0020,596,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064032/0001209191-18-064032-index.htm
2018-12-20SCOTT D SANDELL10% Share HolderBuy200,000.001.63326,060.0020,596,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064031/0001209191-18-064031-index.htm
2018-12-21Anthony A. Jr. Florence10% Share HolderBuy300,000.001.49448,380.0020,896,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064027/0001209191-18-064027-index.htm
2018-12-21DAVID M MOTT10% Share HolderBuy300,000.001.49448,380.0020,896,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064030/0001209191-18-064030-index.htm
2018-12-21FOREST BASKETT10% Share HolderBuy300,000.001.49448,380.0020,896,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064026/0001209191-18-064026-index.htm
2018-12-21Growth Equity Opportunities IV, LLC10% Share HolderBuy300,000.001.49448,380.0020,896,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064024/0001209191-18-064024-index.htm
2018-12-21JOSHUA MAKOWER10% Share HolderBuy300,000.001.49448,380.0020,896,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064029/0001209191-18-064029-index.htm
2018-12-21Mohamad Makhzoumi10% Share HolderBuy300,000.001.49448,380.0020,896,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064028/0001209191-18-064028-index.htm
2018-12-21PETER J BARRIS10% Share HolderBuy300,000.001.49448,380.0020,896,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064025/0001209191-18-064025-index.htm
2018-12-21Peter W. Sonsini10% Share HolderBuy300,000.001.49448,380.0020,896,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064032/0001209191-18-064032-index.htm
2018-12-21SCOTT D SANDELL10% Share HolderBuy300,000.001.49448,380.0020,896,038.00https://www.sec.gov/Archives/edgar/data/1325879/000120919118064031/0001209191-18-064031-index.htm
2019-04-08Anthony A. Jr. Florence10% Share HolderBuy4,347,827.001.144,956,522.7825,243,865.00https://www.sec.gov/Archives/edgar/data/1325879/000120919119023998/0001209191-19-023998-index.htm
2019-04-08DAVID M MOTT10% Share HolderBuy4,347,827.001.144,956,522.7825,243,865.00https://www.sec.gov/Archives/edgar/data/1325879/000120919119024002/0001209191-19-024002-index.htm
2019-04-08FOREST BASKETT10% Share HolderBuy4,347,827.001.144,956,522.7825,243,865.00https://www.sec.gov/Archives/edgar/data/1325879/000120919119023997/0001209191-19-023997-index.htm
2019-04-08Growth Equity Opportunities Fund IV, LLC10% Share HolderBuy4,347,827.001.144,956,522.7825,243,865.00https://www.sec.gov/Archives/edgar/data/1325879/000120919119023995/0001209191-19-023995-index.htm
2019-04-08JOSHUA MAKOWER10% Share HolderBuy4,347,827.001.144,956,522.7825,243,865.00https://www.sec.gov/Archives/edgar/data/1325879/000120919119024000/0001209191-19-024000-index.htm
2019-04-08Mohamad Makhzoumi10% Share HolderBuy4,347,827.001.144,956,522.7825,243,865.00https://www.sec.gov/Archives/edgar/data/1325879/000120919119023999/0001209191-19-023999-index.htm
2019-04-08PETER J BARRIS10% Share HolderBuy4,347,827.001.144,956,522.7825,243,865.00https://www.sec.gov/Archives/edgar/data/1325879/000120919119023996/0001209191-19-023996-index.htm
2019-04-08Peter W. Sonsini10% Share HolderBuy4,347,827.001.144,956,522.7825,243,865.00https://www.sec.gov/Archives/edgar/data/1325879/000120919119024005/0001209191-19-024005-index.htm
2019-04-08SCOTT D SANDELL10% Share HolderBuy4,347,827.001.144,956,522.7825,243,865.00https://www.sec.gov/Archives/edgar/data/1325879/000120919119024004/0001209191-19-024004-index.htm
2019-11-21MICHAEL P BAILEYPresident & CEOBuy150,000.000.6089,595.00318,848.00https://www.sec.gov/Archives/edgar/data/1325879/000089924319028068/0000899243-19-028068-index.htm
2020-06-19Anthony A. Jr. Florence10% Share HolderBuy1,428,571.005.257,499,997.753,952,958.00https://www.sec.gov/Archives/edgar/data/1325879/000120919120038238/0001209191-20-038238-index.htm
2020-06-19FOREST BASKETT10% Share HolderBuy1,428,571.005.257,499,997.753,952,958.00https://www.sec.gov/Archives/edgar/data/1325879/000120919120038235/0001209191-20-038235-index.htm
2020-06-19Growth Equity Opportunities Fund IV, LLC10% Share HolderBuy1,428,571.005.257,499,997.753,952,958.00https://www.sec.gov/Archives/edgar/data/1325879/000120919120038234/0001209191-20-038234-index.htm
2020-06-19JOSHUA MAKOWER10% Share HolderBuy1,428,571.005.257,499,997.753,952,958.00https://www.sec.gov/Archives/edgar/data/1325879/000120919120038243/0001209191-20-038243-index.htm
2020-06-19Mohamad Makhzoumi10% Share HolderBuy1,428,571.005.257,499,997.753,952,958.00https://www.sec.gov/Archives/edgar/data/1325879/000120919120038240/0001209191-20-038240-index.htm
2020-06-19Peter W. Sonsini10% Share HolderBuy1,428,571.005.257,499,997.753,952,958.00https://www.sec.gov/Archives/edgar/data/1325879/000120919120038246/0001209191-20-038246-index.htm
2020-06-19SCOTT D SANDELL10% Share HolderBuy1,428,571.005.257,499,997.753,952,958.00https://www.sec.gov/Archives/edgar/data/1325879/000120919120038244/0001209191-20-038244-index.htm